personal use of i-o therapy in advanced-stage nsclc
Published 5 years ago • 139 plays • Length 7:26Download video MP4
Download video MP3
Similar videos
-
5:51
the potential for io use as maintenance therapy in nsclc - o
-
3:01
overview of novel therapy for advanced-stage nsclc
-
5:58
continuing/re-challenging with i-o therapy in nsclc
-
3:28
treatment after progression in advanced-stage nsclc
-
11:22
treatment of locally advanced nsclc
-
9:57
practical considerations for immunotherapy in stage 3 nsclc
-
7:35
i-o therapy versus surgery or chemotherapy in nsclc
-
4:16
upfront pd-1 inhibitor monotherapy in advanced nsclc
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
1:18
dr. natale on the evolution of immunotherapy in nsclc
-
5:36
treatment of early-stage nsclc
-
4:07
chemotherapy with i-o therapy in egfr- or alk-mutated nsclc
-
5:55
surgery options for nsclc & i-o therapy in egfr-mutations
-
3:48
i-o as first-line therapy for driver-mutated nsclc
-
1:00:44
practical application of recent clinical data for immunotherapy in nsclc
-
1:02:36
practice changes for use of immunotherapy in nsclc
-
5:03
immunotherapy in metastatic nsclc
-
53:49
the role of immunotherapy in late stage nsclc webinar
-
7:01
actual use of pembrolizumab and chemotherapy in nsclc